首站-论文投稿智能助手
典型文献
Therapeutic cell engineering:designing programmable synthetic genetic circuits in mammalian cells
文献摘要:
Cell therapy approaches that employ engineered mam-malian cells for on-demand production of therapeutic agents in the patient's body are moving beyond proof-of-concept in translational medicine.The therapeutic cells can be customized to sense user-defined signals,pro-cess them,and respond in a programmable and pre-dictable way.In this paper,we introduce the available tools and strategies employed to design therapeutic cells.Then,various approaches to control cell behav-iors,including open-loop and closed-loop systems,are discussed.We also highlight therapeutic applications of engineered cells for early diagnosis and treatment of various diseases in the clinic and in experimental dis-ease models.Finally,we consider emerging technolo-gies such as digital devices and their potential for incorporation into future cell-based therapies.
文献关键词:
作者姓名:
Maysam Mansouri;Martin Fussenegger
作者机构:
Department of Biosystems Science and Engineering,ETH Zurich,Mattenstrasse 26,4058 Basel,Switzerland;Faculty of Science,University of Basel,Mattenstrasse 26,4058 Basel,Switzerland
文献出处:
引用格式:
[1]Maysam Mansouri;Martin Fussenegger-.Therapeutic cell engineering:designing programmable synthetic genetic circuits in mammalian cells)[J].蛋白质与细胞,2022(07):476-489
A类:
dictable
B类:
Therapeutic,engineering,designing,programmable,synthetic,genetic,circuits,mammalian,cells,Cell,therapy,approaches,that,engineered,demand,production,therapeutic,agents,patient,body,are,moving,beyond,proof,concept,translational,medicine,can,customized,sense,user,defined,signals,cess,them,respond,pre,way,In,this,paper,we,introduce,available,tools,strategies,employed,Then,various,control,behav,iors,including,open,loop,closed,systems,discussed,We,also,highlight,applications,early,diagnosis,treatment,diseases,clinic,experimental,models,Finally,consider,emerging,technolo,such,digital,devices,their,potential,incorporation,into,future,therapies
AB值:
0.661439
相似文献
Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response
Jingjing He;Xinxin Xiong;Han Yang;Dandan Li;Xuefei Liu;Shuo Li;Shuangye Liao;Siyu Chen;Xizhi Wen;Kuai Yu;Lingyi Fu;Xingjun Dong;Kaiyu Zhu;Xiaojun Xia;Tiebang Kang;Chaochao Bian;Xiang Li;Haiping Liu;Peirong Ding;Xiaoshi Zhang;Zhenjiang Liu;Wende Li;Zhixiang Zuo;Penghui Zhou-State Key Laboratory of Oncology in Southern China,Collaborative Innovation Center for Cancer Medicine,Sun Yat-sen University Cancer Center,Guangzhou,China;Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou,China;Guangdong Laboratory Animals Monitoring Institute,Guangdong Key Laboratory of Laboratory Animals,Guangzhou,China;Guangzhou Finelmmune Biotechnology Co.,LTD,Guangzhou,China
Acquisition of taxane resistance by p53 inactivation in ovarian cancer cells
Changfa Shu;Xi Zheng;Alafate Wuhafu;Danielle Cicka;Sean Doyle;Qiankun Niu;Dacheng Fan;Kun Qian;Andrey A.Ivanov;Yuhong Du;Xiulei Mo;Haian Fu-Department of Pharmacology and Chemical Biology,Emory University School of Medicine,Atlanta,GA 30322,USA;Department of Gynecology and Obstetrics,The Third Xiangya Hospital of Central South University,Changsha 410013,China;Cancer Institute,the Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310052,China;The First Affiliated Hospital,Medical School of Xi'an Jiaotong University,Xi'an 710061,China;Emory Chemical Biology Discovery Center,Emory University School of Medicine,Atlanta,GA 30322,USA;Department of Hematology and Medical Oncology and Winship Cancer Institute,Emory University,Atlanta,GA 30322,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。